Art

J-GLOBAL ID：201802230621686952   Reference number：18A0418560

The thymus and activation-regulated chemokine (TARC) level in serum at an early stage of a drug eruption is a prognostic biomarker of severity of systemic inflammation

薬疹の早期ステージでの血清中の胸腺及び活性化制御性ケモカイン(TARC)レベルは全身性炎症の重症度の予後バイオマーカである

Author (8)： Komatsu-Fujii Takayoshi (Department of Dermatology, Shimane University Faculty of Medicine) ,  Chinuki Yuko (Department of Dermatology, Shimane University Faculty of Medicine) ,  Niihara Hiroyuki (Department of Dermatology, Shimane University Faculty of Medicine) ,  Hayashida Kenji (Department of Dermatology, Shimane University Faculty of Medicine) ,  Ohta Masataka (Department of Dermatology, Shimane University Faculty of Medicine) ,  Okazaki Ryota (Department of Laboratory Medicine, Shimane University Hospital) ,  Kaneko Sakae (Department of Dermatology, Shimane University Faculty of Medicine) ,  Morita Eishin (Department of Dermatology, Shimane University Faculty of Medicine)
Material： Allergology International  (Allergol Int)
Volume： 67  Issue： 1  Page： 90-95(J-STAGE)  Publication year： 2018 
JST Material Number： L6446A  ISSN： 1323-8930  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *drug eruption ,...
Semi thesaurus term： *TARC ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0418560&from=J-GLOBAL&jstjournalNo=L6446A") }}

Author keywords (10)： Drug eruption ,  Glasgow prognostic score (GPS) ,  Systemic inflammatory response syndrome (SIRS) ,  Neutrophil to lymphocyte ratio (NLR) ,  Thymus and activation-regulated chemokine (TARC) ,  Drug eruption ,  Glasgow prognostic score (GPS) ,  Systemic inflammatory response syndrome (SIRS) ,  Neutrophil to lymphocyte ratio (NLR) ,  Thymus and activation-regulated chemokine (TARC)

JST classification (1)： Skin diseases  (GF03000Q)

Reference (26)：

• 1. Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol 2008;58:33-40.
• 2. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007;156:1083-4.
• 3. Mockenhaupt M. Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management. Semin Cutan Med Surg 2014;33:10-6.
• 4. Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 2010;106:470-6.
• 5. Namiuchi S, Sugie T, Saji K, Takii T, Suda A, Kato A. The systemic inflammation-based Glasgow Prognostic Score as a prognostic factor in patients with acute heart failure. J Cardiovasc Med 2015;16:409-15.

Terms in the title (10)： 薬疹 ,  早期 ,  ステージ ,  血清 ,  胸腺及び活性化制御性ケモカイン ,  TARC ,  全身性炎症 ,  重症度 ,  予後 ,  バイオマーカ